Investment Strategies News 7 October 2025

AI Hype vs Reality: HPE Stock’s Wild October Ride and What’s Next for Investors

HPE Stock Volatility: From Highs to a Post-Guidance Slump Hewlett Packard Enterprise headquarters in Texas. The company’s stock has experienced volatility amid surging AI enthusiasm and cautious financial guidance. After a steady climb through 2025, HPE’s stock rally hit turbulence

22 October 2025

Artificial Intelligence·Financial Analysis·Investment Strategies·Stock Market·Technology Trends

SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

Q3 Earnings Recap: Resilient Results Amid Oil Slowdown SLB’s third-quarter 2025 results, released on Oct 17, showed better-than-expected profitability even as industry conditions softened. The company earned $0.69 per share (adj.) for Q3, topping estimates of $0.66 Tipranks. Revenue came

17 October 2025

Company Analysis·Earnings Reports·Investment Strategies·Oil Industry·Stock Market

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

In summary, Artiva Biotherapeutics stock has erupted in October 2025 on the back of a major FDA Fast Track win and renewed optimism around its NK-cell therapy for RA. The latest developments – from surging share price and volume to

17 October 2025

Biotech News·FDA Approvals·Financial Analysis·Investment Strategies·Stock Market

Gold & Silver Hit Record Highs in Safe-Haven Frenzy – $5,000 Next or 2026 Crash?

Gold Soars to Record Highs Amid Global Angst Gold’s price blew past historic milestones this October as anxious investors flocked to safe-haven assets. The metal first breached the $4,000/oz barrier in early October – a level never seen before –

17 October 2025

Economic Analysis·Financial Forecasts·Investment Strategies·Market Trends·Precious Metals

Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next

Surge Fueled by a ‘100-Bagger’ Tweet Sana Biotechnology’s stock skyrocketed mid-week after a bold endorsement from a well-known tech investor. On Oct. 15, SANA shares jumped over 25% in a single session, closing at $5.62 (up from $4.45 the day

16 October 2025

Biotechnology·Financial News·Investment Strategies·Market Analysis·Stock Market

BCE Stock’s Wild Ride: Dividend Drama, Bold Turnaround Plan & Analyst Predictions

Stock Price Check: Recent Movements As of October 14, 2025, BCE Inc.’s stock is trading around the mid-C$33 range after a period of extreme volatility. It closed at C$33.41 on the Toronto Stock Exchange, notching a slight decline on the

14 October 2025

Company Analysis·Dividends·Financial News·Investment Strategies·Stock Market

Wall Street Panic: Howard Marks Warns of AI Bubble as Gold Hits Record High and Under-the-Radar Stocks Explode

Howard Marks: 35 Years of Memos and Modern Warnings Howard Marks’ famous memos have been required reading on Wall Street for decades – so much so that Buffett reportedly gave them to protégés. In reflecting on his career, Marks underscores

13 October 2025

Artificial Intelligence·Financial News·Gold Prices·Investment Strategies·Stock Market

Walmart Stock Soars: Will It Hit $1 Trillion by 2026? Key Analysis & Forecast

Stock Price & Performance WMT has been a standout in retail this year. Its share price trades just under $102 Investing and is a few dollars off its 52-week peak (~$106). Over the past 12 months it’s gained roughly 30%,

12 October 2025

Financial Forecasts·Investment Strategies·Market Trends·Stock Market

Gold vs Silver Showdown: Record Prices, Key Trends & Investment Outlook 2025

Gold and Silver as Investment Assets Gold and silver have captivated humankind for millennia – treasured as stores of value, mediums of exchange, and symbols of wealth. Both are classified as precious metals, but they play distinct roles in today’s

10 October 2025

Financial Analysis·Investment Strategies·Market Trends·Precious Metals

Adaptimmune Stock’s Wild 2025 Ride: Speculative Surge or True Biotech Comeback?

Company Overview: Pioneering T-Cell Therapies for Cancer Adaptimmune Therapeutics plc is a UK-based biotech founded in 2008, specializing in T-cell receptor (TCR) engineered cell therapies to fight cancer ts2.tech. The company’s mission has been to “redefine how some of the

9 October 2025

Biotech Stocks·Financial News·Investment Strategies·Market Analysis

Ferrari Stock Skids as EV Ambitions Shift: Inside RACE’s High-Octane Gamble

Ferrari in the Headlines: New Strategic Plan & Stock Shock In early October 2025, Ferrari N.V. held a high-profile Capital Markets Day (investor day) in Maranello, unveiling its 2030 strategic plan and updated guidance. The event proved dramatic – Ferrari’s

9 October 2025

Automotive Industry·Electric Vehicles·Investment Strategies·Stock Market

Diagnex Inc. (DGNX) Stock Skyrockets in 2025 – An Epic ESG Tech Rally and What’s Next

Diginex (DGNX) Stock Skyrockets 3,000% – Latest News, Expert Insights & 2025 Outlook

Overview: An ESG Tech High-Flyer with a 3,000% Rally Diginex Limited is a London-headquartered “Sustainability RegTech” company providing cloud-based software for ESG (Environmental, Social, Governance) data reporting and compliance ts2.tech. In essence, Diginex’s platforms help organizations track and disclose sustainability

7 October 2025

Cryptocurrency·Investment Strategies·Market News·Stocks

Investment Strategies News 7 October 2025 - 22 October 2025